Clinuvel Pharmaceuticals Limited (ASX:CUV)
Australia · Delayed Price · Currency is AUD 9.66
-0.09 (-0.92%)
At close: Mar 18, 2026
Clinuvel Pharmaceuticals Market Cap
Clinuvel Pharmaceuticals has a market cap or net worth of 484.94 million as of March 18, 2026. Its market cap has decreased by -25.49% in one year.
Market Cap
484.94M
Enterprise Value
252.26M
Revenue
96.30M
Ranking
n/a
PE Ratio
15.01
Stock Price
9.66
Market Cap Chart
Since February 13, 2001, Clinuvel Pharmaceuticals's market cap has increased from 5.23M to 484.94M, an increase of 9,179.95%. That is a compound annual growth rate of 19.78%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 17, 2026 | 489.46M | -21.75% |
| Dec 31, 2025 | 625.50M | 3.84% |
| Dec 31, 2024 | 602.36M | -24.90% |
| Dec 29, 2023 | 802.04M | -25.09% |
| Dec 30, 2022 | 1.07B | -20.36% |
| Dec 31, 2021 | 1.34B | 21.91% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Neuren Pharmaceuticals | 1.44B |
| PYC Therapeutics | 1.34B |
| Clarity Pharmaceuticals | 1.27B |
| Opthea | 738.77M |
| Racura Oncology | 432.54M |
| Tetratherix | 284.29M |
| Dimerix | 231.15M |
| Orthocell | 211.62M |